ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,539Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 288

$700K Total Retail Price of All Prescriptions

Rank: 26 out of 288

567 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,554 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
FUROSEMIDE 549 454 1 5
AMLODIPINE BESYLATE 426 333 2 6
OMEPRAZOLE 318 249 3 3
SIMVASTATIN 272 228 4 1
LEVOTHYROXINE SODIUM 216 159 5 2
ALLOPURINOL 210 197 6 23
POTASSIUM CHLORIDE 205 175 7 11
METOPROLOL SUCCINATE 203 178 8 15
LISINOPRIL 186 158 9 4
HYDROCODONE-ACETAMINOPHEN 156 116 S3 10 7
BYSTOLIC 151 129 11 96
RENVELA 144 94 12 181
GABAPENTIN 141 114 13 17
METOPROLOL TARTRATE 135 103 14 8
LANTUS 134 102 15 31
AMLODIPINE BESYLATE-BENAZEPRIL 133 116 16 89
BENAZEPRIL HCL 132 108 17 52
LANTUS SOLOSTAR 129 106 18 81
METFORMIN HCL 113 100 19 12
WARFARIN SODIUM 107 82 20 9
GLIMEPIRIDE 107 102 20 32
PREDNISONE 105 91 22 30
ZOLPIDEM TARTRATE 95 76 23 22
ROPINIROLE HCL 93 54 24 74
LOSARTAN POTASSIUM 93 63 24 16
ATORVASTATIN CALCIUM 93 75 24 14
TORSEMIDE 90 73 27 134
SPIRONOLACTONE 89 78 28 36
SENSIPAR 85 39 29 211
CLOPIDOGREL 80 63 30 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 48 31 113
TERAZOSIN HCL 73 55 31 85
TRAMADOL HCL 72 63 33 19
CALCITRIOL 71 63 34 226
PANTOPRAZOLE SODIUM 71 56 34 42
PEN NEEDLE 71 37 34 100
CEPHALEXIN 68 58 37 83
TAMSULOSIN HCL 67 67 38 24
DONEPEZIL HCL 65 65 39 29
INSULIN SYRINGE 64 48 40 79
CHLORTHALIDONE 62 56 41 149
NOVOLOG 60 43 42 91
PLAVIX 60 57 42 71
CARVEDILOL 60 49 42 27
CITALOPRAM HBR 57 46 45 18
ATENOLOL 57 46 45 10
TRAZODONE HCL 53 46 47 37
METOLAZONE 52 46 48 216
FLUTICASONE PROPIONATE 51 40 49 41
GLIPIZIDE 51 51 49 56
MIDODRINE HCL 51 39 49 351
DIOVAN 50 50 52 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.